Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TtbioROCO:6493 +3.17%70 EV-to-EBITDA is 49.10 as of Sep. 11, 2026, which is 362% above its 10-year median of 10.62. GuruFocus rates ROCO:6493 with a GF Score™ of 70/100 and a GF Value™ of NT$22.52 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 516 Medical Devices & Instruments companies, Ttbio ranks worse than 87.6% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Ttbio's enterprise value is NT$1,330.2 Mil.
Ttbio's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was NT$27.1 Mil. Therefore, Ttbio's EV-to-EBITDA for today is 49.10.
The historical rank and industry rank for Ttbio's EV-to-EBITDA or its related term are showing as below:
ROCO:6493'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.85 Med: 10.62 Max: 84.34
Current: 49.1
During the past 13 years, the highest EV-to-EBITDA of Ttbio was 84.34. The lowest was 5.85. And the median was 10.62.
ROCO:6493's EV-to-EBITDA is ranked worse than 87.6% of 516
companies
in the Medical Devices & Instruments industry
Industry Median: 13.675
vs ROCO:6493: 49.10
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2026-09-11), Ttbio's stock price is NT$39.00.
Ttbio's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was NT$-0.488. Therefore, Ttbio's PE Ratio (TTM) for today is At Loss.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Ttbio's share price for today is NT$39.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ttbio's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was NT$-0.488.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Ttbio's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6493 vs ISRG, BDX, RMD: EV-to-EBITDA Comparison
For the Medical Instruments & Supplies subindustry, Ttbio's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ttbio EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ttbio's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Ttbio's EV-to-EBITDA falls into.
Ttbio's current Enterprise Value is NT$1,330.2 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ttbio's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was NT$27.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ttbio (ROCO:6493) has a EV-to-EBITDA of 49.10 as of Sep. 11, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Ttbio. This is 362% above median its historical median of 10.62. Over the past decade, Ttbio's EV-to-EBITDA has ranged from 5.85 to 84.34. According to the industry distribution chart, Ttbio ranks #452 out of 516 companies in the Medical Devices & Instruments industry, placing it in the top 87.6%.
Is Ttbio's EV-to-EBITDA too high?
Ttbio's current EV-to-EBITDA of 49.10 is 362% above median its 10-year median of 10.62. Over the past 10 years, this metric has ranged from a low of 5.85 to a high of 84.34. The Medical Devices & Instruments industry median EV-to-EBITDA is 13.68. Ttbio's value of 49.10 is 259% above this industry median. Based on the distribution chart, Ttbio ranks #452 out of 516 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Ttbio has a GF Score™ of 70/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ttbio's EV-to-EBITDA compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Ttbio ranks #452 out of 516 companies for EV-to-EBITDA. This places Ttbio in the lower half of its industry. The industry median EV-to-EBITDA is 13.68. Ttbio's value of 49.10 is 259% above this benchmark. Historically, Ttbio's own EV-to-EBITDA has ranged from 5.85 to 84.34 over the past decade. While the company's 10-year median is 10.62 vs. the industry median of 13.68, Ttbio has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 13.68, based on 516 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ttbio's current EV-to-EBITDA of 49.10 is 259% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Ttbio. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 13.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ttbio's current EV-to-EBITDA is 49.10, which is 362% above median its own 10-year median of 10.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ttbio stock overvalued right now?
Based on GuruFocus' analysis, Ttbio (ROCO:6493) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$22.52, compared to a current price of NT$39.00 — trading 73.2% above its estimated fair value. The current EV-to-EBITDA is 49.10, which is 362% above median its 10-year median of 10.62 and 259% above the Medical Devices & Instruments industry median of 13.68. Ttbio's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Ttbio (ROCO:6493), the current EV-to-EBITDA is 49.10 as of Sep. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ttbio (ROCO:6493) Overvalued in 2026?
Based on GuruFocus' analysis, Ttbio stock appears to be overvalued.
The current stock price of NT$39.00 is trading 73.2% above its estimated GF Value™ of NT$22.52.
GuruFocus considers Ttbio to be Significantly Overvalued.
Key valuation signals for ROCO:6493:
EV-to-EBITDA: 49.10 (362% above median its 10-year median of 10.62)
GF Value™: NT$22.52 vs. price of NT$39.00 (73.2% above fair value)
Industry Position: 259% above the Medical Devices & Instruments median (#452 of 516)
No single metric tells the full story. See the ROCO:6493 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ttbio Corp is a Taiwan based company engaged in the manufacturing of dental products and accessories. Its products include High-Speed Handpiece Series, Low-Speed Handpiece Series, Dental Spare Parts, Service Rotor, and Maintenance Unit among others.
70GF Score
Get the complete analysis for ROCO:6493
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6493 has been successfully added to your 
